DxDiscovery, Inc.

DXDISCOVERY

Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, invasive candidiasis, Lyme disease, Pertussis, Cryptococcosis, Dermatophyte infection, Mucormycosis, Huanglongbing, and Bacillus anthracis (anthrax); Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Immunoassay reagents for medical use; Medical diagnostic reagents and assays for testing body fluids for microorganisms;DX DISCOVERY;Assays for research purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use;Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Pharmaceutical research and development; Research and development services in the field of antibodies; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of immunoassay; Research and development of vaccines and medicines; Scientific research and development; Vaccine research and development;